Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 680

1.

"Duckweed-Microbe Co-Cultivation Method" for Isolating a Wide Variety of Microbes Including Taxonomically Novel Microbes.

Tanaka Y, Tamaki H, Tanaka K, Tozawa E, Matsuzawa H, Toyama T, Kamagata Y, Mori K.

Microbes Environ. 2018 Nov 7. doi: 10.1264/jsme2.ME18067. [Epub ahead of print]

2.

Effects of serum estradiol and progesterone on estrogen-regulated gene expression in breast cancers of premenopausal patients.

Wanifuchi-Endo Y, Asano T, Kondo N, Hato Y, Dong Y, Hisada T, Nishikawa S, Kato H, Takahashi S, Okuda K, Yamashita H, Toyama T.

Jpn J Clin Oncol. 2018 Nov 5. doi: 10.1093/jjco/hyy156. [Epub ahead of print]

PMID:
30395264
3.

Visual acuity improvement after phacoemulsification cataract surgery in patients aged ≥90 years.

Toyama T, Ueta T, Yoshitani M, Sakata R, Numaga J.

BMC Ophthalmol. 2018 Oct 29;18(1):280. doi: 10.1186/s12886-018-0950-8.

4.

Erythropoietin signal protected HUVEC from high glucose induced injury.

Yasuda H, Iwata Y, Nakajima S, Furuichi K, Miyake T, Sakai N, Kitajima S, Toyama T, Shinozaki Y, Sagara A, Miyagawa T, Hara A, Shimizu M, Kamikawa Y, Sato K, Oshima M, Yoneda-Nakagawa S, Kaneko S, Wada T.

Nephrology (Carlton). 2018 Oct 22. doi: 10.1111/nep.13518. [Epub ahead of print]

PMID:
30346085
5.

Gut microbiota-derived D-serine protects against acute kidney injury.

Nakade Y, Iwata Y, Furuichi K, Mita M, Hamase K, Konno R, Miyake T, Sakai N, Kitajima S, Toyama T, Shinozaki Y, Sagara A, Miyagawa T, Hara A, Shimizu M, Kamikawa Y, Sato K, Oshima M, Yoneda-Nakagawa S, Yamamura Y, Kaneko S, Miyamoto T, Katane M, Homma H, Morita H, Suda W, Hattori M, Wada T.

JCI Insight. 2018 Oct 18;3(20). pii: 97957. doi: 10.1172/jci.insight.97957. [Epub ahead of print]

6.

Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational study.

Sumida H, Asano Y, Tamaki Z, Aozasa N, Taniguchi T, Toyama T, Takahashi T, Ichimura Y, Noda S, Akamata K, Saigusa R, Miyazaki M, Kuwano Y, Yanaba K, Yoshizaki A, Sato S.

J Dermatol. 2018 Oct 5. doi: 10.1111/1346-8138.14669. [Epub ahead of print]

PMID:
30289572
7.

Yokukansan Ameliorates Hippocampus-Dependent Learning Impairment in Senescence-Accelerated Mouse.

Azuma K, Toyama T, Katano M, Kajimoto K, Hayashi S, Suzuki A, Tsugane H, Iinuma M, Kubo KY.

Biol Pharm Bull. 2018;41(10):1593-1599. doi: 10.1248/bpb.b18-00359.

8.

Increased expression of aquaporin-1 in dermal fibroblasts and dermal microvascular endothelial cells possibly contributes to skin fibrosis and edema in patients with systemic sclerosis.

Yamashita T, Asano Y, Saigusa R, Taniguchi T, Nakamura K, Miura S, Toyama T, Takahashi T, Ichimura Y, Hirabayashi M, Yoshizaki A, Miyagaki T, Sugaya M, Sato S.

J Dermatol Sci. 2018 Sep 21. pii: S0923-1811(18)30375-X. doi: 10.1016/j.jdermsci.2018.09.007. [Epub ahead of print]

PMID:
30270117
9.

Progranulin overproduction due to constitutively activated c-Abl/PKC-δ/Fli1 pathway contributes to the resistance of dermal fibroblasts to the anti-fibrotic effect of tumor necrosis factor-α in localized scleroderma.

Miyagawa T, Ichimura Y, Nakamura K, Hirabayashi M, Yamashita T, Saigusa R, Miura S, Takahashi T, Toyama T, Taniguchi T, Akamata K, Yoshizaki A, Sato S, Asano Y.

J Dermatol Sci. 2018 Sep 19. pii: S0923-1811(18)30369-4. doi: 10.1016/j.jdermsci.2018.09.005. [Epub ahead of print]

PMID:
30268392
10.

Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.

Lo C, Toyama T, Wang Y, Lin J, Hirakawa Y, Jun M, Cass A, Hawley CM, Pilmore H, Badve SV, Perkovic V, Zoungas S.

Cochrane Database Syst Rev. 2018 Sep 24;9:CD011798. doi: 10.1002/14651858.CD011798.pub2. Review.

PMID:
30246878
11.

Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study.

Iwata H, Masuda N, Yamamoto Y, Fujisawa T, Toyama T, Kashiwaba M, Ohtani S, Taira N, Sakai T, Hasegawa Y, Nakamura R, Akabane H, Shibahara Y, Sasano H, Yamaguchi T, Sakamaki K, Bailey H, Cherbavaz DB, Jakubowski DM, Sugiyama N, Chao C, Ohashi Y.

Breast Cancer Res Treat. 2018 Sep 21. doi: 10.1007/s10549-018-4964-y. [Epub ahead of print]

PMID:
30242578
12.

Differences in Adherence Barriers to Inhaled Medicines between Japanese Patients with Chronic Obstructive Pulmonary Disease and Asthma Evaluated using the "Adherence Starts with Knowledge 20" (ASK-20) Questionnaire.

Toyama T, Kawayama T, Kinoshita T, Imamura Y, Yoshida M, Takahashi K, Fujii K, Higashimoto I, Hoshino T.

Intern Med. 2018 Sep 12. doi: 10.2169/internalmedicine.0488-17. [Epub ahead of print]

13.

Diabetic Nephropathy: A Comparison of the Clinical and Pathological Features between the CKD Risk Classification and the Classification of Diabetic Nephropathy 2014 in Japan.

Furuichi K, Shimizu M, Hara A, Toyama T, Wada T.

Intern Med. 2018 Aug 10. doi: 10.2169/internalmedicine.1132-18. [Epub ahead of print]

14.

Activation of ornithine decarboxylase protects against methylmercury toxicity by increasing putrescine.

Sato M, Toyama T, Lee JY, Miura N, Naganuma A, Hwang GW.

Toxicol Appl Pharmacol. 2018 Oct 1;356:120-126. doi: 10.1016/j.taap.2018.08.002. Epub 2018 Aug 4.

PMID:
30081057
15.

Estimated glomerular filtration rate decline and risk of end-stage renal disease in type 2 diabetes.

Oshima M, Toyama T, Haneda M, Furuichi K, Babazono T, Yokoyama H, Iseki K, Araki S, Ninomiya T, Hara S, Suzuki Y, Iwano M, Kusano E, Moriya T, Satoh H, Nakamura H, Shimizu M, Hara A, Makino H, Wada T; Research Group of Diabetic Nephropathy, Ministry of Health, Labour, and Welfare of Japan.

PLoS One. 2018 Aug 2;13(8):e0201535. doi: 10.1371/journal.pone.0201535. eCollection 2018.

16.

Effect of activated carbon on removal of four phenolic endocrine-disrupting compounds, bisphenol A, bisphenol F, bisphenol S, and 4-tert-butylphenol in constructed wetlands.

Wirasnita R, Mori K, Toyama T.

Chemosphere. 2018 Nov;210:717-725. doi: 10.1016/j.chemosphere.2018.07.060. Epub 2018 Jul 17.

PMID:
30036819
17.

A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PRECIOUS study.

Yamamoto Y, Iwata H, Ueno T, Taira N, Kashiwaba M, Takahashi M, Tada H, Tsugawa K, Toyama T, Niikura N, Hara F, Fujisawa T, Yoshinami T, Saji S, Takano T, Masuda N, Morita S, Toi M, Ohno S.

Jpn J Clin Oncol. 2018 Sep 1;48(9):855-859. doi: 10.1093/jjco/hyy097.

PMID:
30020510
18.

Early/prefibrotic primary myelofibrosis in patients who were initially diagnosed with essential thrombocythemia.

Kamiunten A, Shide K, Kameda T, Ito M, Sekine M, Kubuki Y, Hidaka T, Akizuki K, Tahira Y, Toyama T, Kawano N, Marutsuka K, Maeda K, Takeuchi M, Kawano H, Sato S, Ishizaki J, Shimoda H, Yamashita K, Matsuoka H, Shimoda K.

Int J Hematol. 2018 Jul 9. doi: 10.1007/s12185-018-2495-2. [Epub ahead of print]

PMID:
29987745
19.

Chemokine CCL4 Induced in Mouse Brain Has a Protective Role against Methylmercury Toxicity.

Takahashi T, Kim MS, Iwai-Shimada M, Fujimura M, Toyama T, Naganuma A, Hwang GW.

Toxics. 2018 Jul 7;6(3). pii: E36. doi: 10.3390/toxics6030036.

20.

Growth promotion of three microalgae, Chlamydomonas reinhardtii, Chlorella vulgaris and Euglena gracilis, by in situ indigenous bacteria in wastewater effluent.

Toyama T, Kasuya M, Hanaoka T, Kobayashi N, Tanaka Y, Inoue D, Sei K, Morikawa M, Mori K.

Biotechnol Biofuels. 2018 Jun 25;11:176. doi: 10.1186/s13068-018-1174-0. eCollection 2018.

21.

Effects of French Pine Bark Extract Chewing Gum on Oral Malodor and Salivary Bacteria.

Watanabe K, Hiramine H, Toyama T, Hamada N.

J Nutr Sci Vitaminol (Tokyo). 2018;64(3):185-191. doi: 10.3177/jnsv.64.185.

22.

A randomized phase II study evaluating pyridoxine for the prevention of hand-foot syndrome associated with capecitabine therapy for advanced or metastatic breast cancer.

Toyama T, Yoshimura A, Hayashi T, Kobayashi N, Saito K, Tsuneizumi M, Sawaki M, Hattori M, Nakada T, Yokota I, Iwata H.

Breast Cancer. 2018 Nov;25(6):729-735. doi: 10.1007/s12282-018-0879-z. Epub 2018 Jun 8.

PMID:
29948956
23.

CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosis.

Taniguchi T, Miyagawa T, Toyama S, Yamashita T, Nakamura K, Saigusa R, Ichimura Y, Takahashi T, Toyama T, Yoshizaki A, Sato S, Asano Y.

Exp Dermatol. 2018 Sep;27(9):1030-1037. doi: 10.1111/exd.13724. Epub 2018 Jul 29.

PMID:
29947047
24.

Clinicopathological predictors for progression of chronic kidney disease in nephrosclerosis: a biopsy-based cohort study.

Yamanouchi M, Hoshino J, Ubara Y, Takaichi K, Kinowaki K, Fujii T, Ohashi K, Mise K, Toyama T, Hara A, Shimizu M, Furuichi K, Wada T.

Nephrol Dial Transplant. 2018 May 19. doi: 10.1093/ndt/gfy121. [Epub ahead of print]

PMID:
29788462
25.

Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Clinical Trial.

Royce M, Bachelot T, Villanueva C, Özgüroglu M, Azevedo SJ, Cruz FM, Debled M, Hegg R, Toyama T, Falkson C, Jeong J, Srimuninnimit V, Gradishar WJ, Arce C, Ridolfi A, Lin C, Cardoso F.

JAMA Oncol. 2018 Jul 1;4(7):977-984. doi: 10.1001/jamaoncol.2018.0060.

26.

Facile preparation of highly active casein kinase 1 using Escherichia coli constitutively expressing lambda phosphatase.

Akizuki K, Toyama T, Yamashita M, Sugiyama Y, Ishida A, Kameshita I, Sueyoshi N.

Anal Biochem. 2018 May 15;549:99-106. doi: 10.1016/j.ab.2018.03.015. Epub 2018 Mar 17.

PMID:
29559334
27.

[Mixed connective tissue disease with pulmonary hypertension developing in a chronic myeloid leukemia patient on dasatinib treatment].

Watanuki S, Kikuchi T, Toyama T, Abe R, Nakayama H, Karigane D, Shimizu T, Kikuchi J, Matsumoto K, Yasuoka H, Kataoka M, Okamoto S, Mori T.

Rinsho Ketsueki. 2018;59(2):174-177. doi: 10.11406/rinketsu.59.174. Japanese.

PMID:
29515069
28.

Thrombohemorrhagic events, disease progression, and survival in polycythemia vera and essential thrombocythemia: a retrospective survey in Miyazaki prefecture, Japan.

Kamiunten A, Shide K, Kameda T, Sekine M, Kubuki Y, Ito M, Toyama T, Kawano N, Marutsuka K, Maeda K, Takeuchi M, Kawano H, Sato S, Ishizaki J, Akizuki K, Tahira Y, Shimoda H, Hidaka T, Yamashita K, Matsuoka H, Shimoda K.

Int J Hematol. 2018 Jun;107(6):681-688. doi: 10.1007/s12185-018-2428-0. Epub 2018 Feb 27.

PMID:
29488167
29.

Effect of dissolved organic nitrogen contamination on δ15 N-NH4 determination in water samples by modification of the diffusion method with gas-phase trapping.

Cao TTH, Nakamura T, Saiki M, Ta TT, Toyama T, Nishida K.

Rapid Commun Mass Spectrom. 2018 Apr 30;32(8):635-638. doi: 10.1002/rcm.8091.

PMID:
29484730
30.

Fli1-haploinsufficient dermal fibroblasts promote skin-localized transdifferentiation of Th2-like regulatory T cells.

Saigusa R, Asano Y, Taniguchi T, Hirabayashi M, Nakamura K, Miura S, Yamashita T, Takahashi T, Ichimura Y, Toyama T, Yoshizaki A, Trojanowska M, Sato S.

Arthritis Res Ther. 2018 Feb 7;20(1):23. doi: 10.1186/s13075-018-1521-3.

31.

A new pathological scoring system by the Japanese classification to predict renal outcome in diabetic nephropathy.

Hoshino J, Furuichi K, Yamanouchi M, Mise K, Sekine A, Kawada M, Sumida K, Hiramatsu R, Hasegawa E, Hayami N, Suwabe T, Sawa N, Hara S, Fujii T, Ohashi K, Kitagawa K, Toyama T, Shimizu M, Takaichi K, Ubara Y, Wada T.

PLoS One. 2018 Feb 6;13(2):e0190923. doi: 10.1371/journal.pone.0190923. eCollection 2018.

32.

Value of adding the renal pathological score to the kidney failure risk equation in advanced diabetic nephropathy.

Yamanouchi M, Hoshino J, Ubara Y, Takaichi K, Kinowaki K, Fujii T, Ohashi K, Mise K, Toyama T, Hara A, Kitagawa K, Shimizu M, Furuichi K, Wada T.

PLoS One. 2018 Jan 16;13(1):e0190930. doi: 10.1371/journal.pone.0190930. eCollection 2018.

33.

Involvement of p38MAPK in Impaired Neutrophil Bactericidal Activity of Hemodialysis Patients.

Kamikawa Y, Sakai N, Miyake T, Sagara A, Shinozaki Y, Kitajima S, Toyama T, Hara A, Iwata Y, Shimizu M, Furuichi K, Imamura R, Suda T, Kaneko S, Wada T.

Ther Apher Dial. 2018 Jan 10. doi: 10.1111/1744-9987.12651. [Epub ahead of print]

PMID:
29318737
34.

Systemic sclerosis complicated with localized scleroderma-like lesions induced by Köbner phenomenon.

Saigusa R, Asano Y, Yamashita T, Takahashi T, Nakamura K, Miura S, Ichimura Y, Toyama T, Taniguchi T, Sumida H, Tamaki Z, Miyazaki M, Yoshizaki A, Sato S.

J Dermatol Sci. 2018 Mar;89(3):282-289. doi: 10.1016/j.jdermsci.2017.12.005. Epub 2017 Dec 16.

PMID:
29279288
35.

Characterization and Bone Response of Carbonate-Containing Apatite-Coated Titanium Implants Using an Aqueous Spray Coating.

Yagi R, Mochizuki C, Sato M, Toyama T, Hirota M, Hayakawa T, Ohkubo C.

Materials (Basel). 2017 Dec 11;10(12). pii: E1416. doi: 10.3390/ma10121416.

36.

Comprehensive evaluation of nitrogen removal rate and biomass, ethanol, and methane production yields by combination of four major duckweeds and three types of wastewater effluent.

Toyama T, Hanaoka T, Tanaka Y, Morikawa M, Mori K.

Bioresour Technol. 2018 Feb;250:464-473. doi: 10.1016/j.biortech.2017.11.054. Epub 2017 Nov 24.

37.

Nationwide multicenter kidney biopsy study of Japanese patients with hypertensive nephrosclerosis.

Furuichi K, Shimizu M, Yuzawa Y, Hara A, Toyama T, Kitamura H, Suzuki Y, Sato H, Uesugi N, Ubara Y, Hoshino J, Hisano S, Ueda Y, Nishi S, Yokoyama H, Nishino T, Kohagura K, Ogawa D, Mise K, Shibagaki Y, Kimura K, Haneda M, Makino H, Matsuo S, Wada T; Research Group of Diabetic Nephropathy and Nephrosclerosis, Ministry of Health, Labour and Welfare of Japan, and Japan Agency for Medical Research and Development.

Clin Exp Nephrol. 2018 Jun;22(3):629-637. doi: 10.1007/s10157-017-1496-4. Epub 2017 Nov 11.

PMID:
29127556
38.

Sinusitis caused by Exserohilum rostratum after cord blood transplantation for myelodysplastic syndrome: A case report and literature review.

Kohashi S, Toyama T, Hashimoto N, Sakurai M, Kato J, Kikuchi T, Koda Y, Sugita K, Hasegawa N, Yarita K, Kamei K, Okamoto S, Mori T.

Transpl Infect Dis. 2018 Feb;20(1). doi: 10.1111/tid.12805. Epub 2017 Dec 13.

PMID:
29119669
39.

Clinicopathological analysis of biopsy-proven diabetic nephropathy based on the Japanese classification of diabetic nephropathy.

Furuichi K, Shimizu M, Yuzawa Y, Hara A, Toyama T, Kitamura H, Suzuki Y, Sato H, Uesugi N, Ubara Y, Hohino J, Hisano S, Ueda Y, Nishi S, Yokoyama H, Nishino T, Kohagura K, Ogawa D, Mise K, Shibagaki Y, Makino H, Matsuo S, Wada T; Research Group of Diabetic Nephropathy, Ministry of Health, Labour and Welfare of Japan, and Japan Agency for Medical Research and Development.

Clin Exp Nephrol. 2018 Jun;22(3):570-582. doi: 10.1007/s10157-017-1485-7. Epub 2017 Oct 27.

PMID:
29080120
40.

Predictors of mortality in hospital survivors with type 2 diabetes mellitus and acute coronary syndromes.

Savonitto S, Morici N, Nozza A, Cosentino F, Perrone Filardi P, Murena E, Morocutti G, Ferri M, Cavallini C, Eijkemans MJ, Stähli BE, Schrieks IC, Toyama T, Lambers Heerspink HJ, Malmberg K, Schwartz GG, Lincoff AM, Ryden L, Tardif JC, Grobbee DE.

Diab Vasc Dis Res. 2018 Jan;15(1):14-23. doi: 10.1177/1479164117735493. Epub 2017 Oct 20.

PMID:
29052439
41.

A possible implication of reduced levels of LIF, LIFR, and gp130 in vasculopathy related to systemic sclerosis.

Taniguchi T, Miyagawa T, Tamaki Z, Nakamura K, Yamashita T, Saigusa R, Takahashi T, Toyama T, Ichimura Y, Yoshizaki A, Tada Y, Sugaya M, Kadono T, Sato S, Asano Y.

Arch Dermatol Res. 2017 Dec;309(10):833-842. doi: 10.1007/s00403-017-1786-4. Epub 2017 Oct 16.

PMID:
29038846
42.

Genetic and environmental factors and serum hormones, and risk of estrogen receptor-positive breast cancer in pre- and postmenopausal Japanese women.

Guo J, Sueta A, Nakamura K, Yoshimoto N, Baba M, Ishida N, Hagio K, Toyama T, Iwase H, Tamakoshi A, Yamashita H.

Oncotarget. 2017 Aug 11;8(39):65759-65769. doi: 10.18632/oncotarget.20182. eCollection 2017 Sep 12.

43.

Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography with gallium-67 scintigraphy in the initial clinical staging of diffuse large B-cell lymphoma.

Sakurai M, Toyama T, Kikuchi T, Kato J, Shimizu T, Koda Y, Karigane D, Yamane Y, Abe R, Yamazaki R, Nakazato T, Nakahara T, Jinzaki M, Okamoto S, Mori T.

Int J Hematol. 2018 Feb;107(2):194-200. doi: 10.1007/s12185-017-2337-7. Epub 2017 Oct 9.

PMID:
28994017
44.

Enhanced biomass production of duckweeds by inoculating a plant growth-promoting bacterium, Acinetobacter calcoaceticus P23, in sterile medium and non-sterile environmental waters.

Toyama T, Kuroda M, Ogata Y, Hachiya Y, Quach A, Tokura K, Tanaka Y, Mori K, Morikawa M, Ike M.

Water Sci Technol. 2017 Sep;76(5-6):1418-1428. doi: 10.2166/wst.2017.296.

PMID:
28953468
45.

Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.

Ren S, Wang Y, Xian L, Toyama T, Jardine M, Li G, Perkovic V, Hong D.

PLoS One. 2017 Sep 12;12(9):e0184398. doi: 10.1371/journal.pone.0184398. eCollection 2017.

46.

Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS.

Shimizu M, Furuichi K, Toyama T, Funamoto T, Kitajima S, Hara A, Ogawa D, Koya D, Ikeda K, Koshino Y, Kurokawa Y, Abe H, Mori K, Nakayama M, Konishi Y, Samejima KI, Matsui M, Yamauchi H, Gohda T, Fukami K, Nagata D, Yamazaki H, Yuzawa Y, Suzuki Y, Fujimoto S, Maruyama S, Kato S, Naito T, Yoshimura K, Yokoyama H, Wada T; Research Group of Diabetic Nephropathy, the Ministry of Health, Labour, and Welfare of Japan and Japan Agency for Medical Research and Development.

Clin Exp Nephrol. 2018 Apr;22(2):377-387. doi: 10.1007/s10157-017-1467-9. Epub 2017 Sep 9.

PMID:
28889347
47.

Therapeutic Targeting of TAZ and YAP by Dimethyl Fumarate in Systemic Sclerosis Fibrosis.

Toyama T, Looney AP, Baker BM, Stawski L, Haines P, Simms R, Szymaniak AD, Varelas X, Trojanowska M.

J Invest Dermatol. 2018 Jan;138(1):78-88. doi: 10.1016/j.jid.2017.08.024. Epub 2017 Sep 1.

PMID:
28870693
48.

Exposure to Electrophiles Impairs Reactive Persulfide-Dependent Redox Signaling in Neuronal Cells.

Ihara H, Kasamatsu S, Kitamura A, Nishimura A, Tsutsuki H, Ida T, Ishizaki K, Toyama T, Yoshida E, Abdul Hamid H, Jung M, Matsunaga T, Fujii S, Sawa T, Nishida M, Kumagai Y, Akaike T.

Chem Res Toxicol. 2017 Sep 18;30(9):1673-1684. doi: 10.1021/acs.chemrestox.7b00120. Epub 2017 Sep 7.

PMID:
28837763
49.

TRPC6 counteracts TRPC3-Nox2 protein complex leading to attenuation of hyperglycemia-induced heart failure in mice.

Oda S, Numaga-Tomita T, Kitajima N, Toyama T, Harada E, Shimauchi T, Nishimura A, Ishikawa T, Kumagai Y, Birnbaumer L, Nishida M.

Sci Rep. 2017 Aug 8;7(1):7511. doi: 10.1038/s41598-017-07903-4.

50.

Successful Treatment of TAFRO Syndrome with Tocilizumab, Prednisone, and Cyclophosphamide.

Kikuchi T, Shimizu T, Toyama T, Abe R, Okamoto S.

Intern Med. 2017 Aug 15;56(16):2205-2211. doi: 10.2169/internalmedicine.8522-16. Epub 2017 Aug 1. Review.

Supplemental Content

Loading ...
Support Center